For example the Biogen Inc. (NASDAQ:BIIB) share price dropped 56% over five years. That's an unpleasant experience for long term holders. And it's not just long term holders hurting, because the stock ...

Organon (OGN) stock in focus as the Merck (MRK) spinoff buys rights to Biogen's (BIIB) biosimilar Tofidence, targeting ...

American Century Companies Inc. lessened its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 46.8% during the fourth quarter, according to its most recent filing with the Securities ...

Organon (OGN) announced that it has acquired from Biogen (BIIB) regulatory and commercial rights in the U.S. for Tofidence, a biosimilar to ...

Eisai (TYO: 4523) and Biogen (Nasdaq: BIIB) today provided an update on the ongoing regulatory review of the Marketing ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

The S&P 500 Index ($SPX) (SPY) Tuesday closed up +0.38%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.03%, and the Nasdaq 100 Index ($IUXX) (QQQ ...

Trump's Liberation Day tariff plans spare pharmaceuticals for now, with Big Pharma lobbying for gradual measures. Read more ...

Shares of Biogen Inc. shed 3.52% to $132.03 Tuesday, on what proved to be an all-around mixed trading session for the stock ...

Major indices were mostly higher at the close on Tuesday as investors digested a report from the Washington Post that the ...

Major indices were in the red early on Tuesday as investors digested a report from the Washington Post that the White House ...